# Vaccine Construct Validation Report

**Generated:** 2026-06-01
**Pipeline:** SARS-CoV-2 Multi-Epitope Vaccine
**Validation Framework:** ProtParam + VaxiJen + AllerTop analysis

## Validation Criteria

1. **Molecular Weight**: < 50 kDa (optimal for expression)
2. **Stability**: Instability Index < 40 (stable proteins)
3. **Antigenicity**: VaxiJen score >= 0.4 (immunogenic)
4. **Allergenicity**: Low risk (non-allergenic)
5. **Population Coverage**: >= 50% (effective coverage)

## Construct Validation Results

### Version_1_Standard

**Validation Status: NEEDS_OPTIMIZATION**

#### Physicochemical Properties
- **Length**: 171 amino acids
- **Molecular Weight**: 15032.6 Da (15.0 kDa)
- **Theoretical pI**: 10.33
- **Instability Index**: 0.59 (Stable)
- **Aliphatic Index**: 84.09 (Thermostability)
- **GRAVY**: 0.057 (Hydrophobic)

#### Immunogenicity Assessment
- **Antigenicity Score**: 0.212 (FAIL)
- **Allergenicity Risk**: Moderate
- **Population Coverage**: 36.4%

#### Sequence
```
APPHALSGGGSQTLLALHRSYLTPGDGPGPGINITRFQTLLALHRSGPGPGQTLLALHRSYLTGPGPGPIGINITRFQTLLALHRSKKLPFNDGVYFAAYRLFRKSNLKAAYFPNITNLCPFAAYVLYNSASFSTFKAAYVASQSIIAYAAYLYNSASFSTFGGGSPAPAP
```

---

### Version_2_Alternating

**Validation Status: NEEDS_OPTIMIZATION**

#### Physicochemical Properties
- **Length**: 172 amino acids
- **Molecular Weight**: 15063.5 Da (15.1 kDa)
- **Theoretical pI**: 10.12
- **Instability Index**: 0.58 (Stable)
- **Aliphatic Index**: 84.77 (Thermostability)
- **GRAVY**: 0.115 (Hydrophobic)

#### Immunogenicity Assessment
- **Antigenicity Score**: 0.199 (FAIL)
- **Allergenicity Risk**: Moderate
- **Population Coverage**: 36.4%

#### Sequence
```
APPHALSGGGSQTLLALHRSYLTPGDAAYLPFNDGVYFGPGPGINITRFQTLLALHRSAAYRLFRKSNLKGPGPGQTLLALHRSYLTAAYFPNITNLCPFGPGPGPIGINITRFQTLLALHRSAAYVLYNSASFSTFKAAYVASQSIIAYAAYLYNSASFSTFGGGSPAPAP
```

---

### Version_3_Optimized

**Validation Status: NEEDS_OPTIMIZATION**

#### Physicochemical Properties
- **Length**: 144 amino acids
- **Molecular Weight**: 12724.4 Da (12.7 kDa)
- **Theoretical pI**: 10.56
- **Instability Index**: 0.70 (Stable)
- **Aliphatic Index**: 71.94 (Thermostability)
- **GRAVY**: -0.199 (Hydrophilic)

#### Immunogenicity Assessment
- **Antigenicity Score**: 0.251 (FAIL)
- **Allergenicity Risk**: Moderate
- **Population Coverage**: 36.4%

#### Sequence
```
MKKLLFAIPLVVPFYSHSGGGSAPPHALSGPGPGQTLLALHRSYLTPGDGPGPGINITRFQTLLALHRSKKGPGPGKKLPFNDGVYFAAYRLFRKSNLKAAYFPNITNLCPFAAYVLYNSASFSTFKGGGSPAPAPGSHHHHHH
```

---

## Construct Comparison Summary

| Construct | Status | Length | MW (kDa) | pI | Antigenicity | Allergenicity |
|-----------|--------|--------|----------|----|--------------|--------------|
| Version_1_Standard | NEEDS_OPTIMIZATION | 171 | 15.0 | 10.33 | 0.212 | Moderate |
| Version_2_Alternating | NEEDS_OPTIMIZATION | 172 | 15.1 | 10.12 | 0.199 | Moderate |
| Version_3_Optimized | NEEDS_OPTIMIZATION | 144 | 12.7 | 10.56 | 0.251 | Moderate |

## Recommendations

**Recommended Construct**: Version_1_Standard
- **Rationale**: NEEDS_OPTIMIZATION validation status
- **Key Strengths**: optimal size, stable

## Next Steps

1. **Web Tool Validation**: Submit to VaxiJen and AllerTop for accurate scoring
2. **Structural Analysis**: 3D structure prediction with ColabFold
3. **Molecular Docking**: Interaction analysis with immune receptors
4. **In Silico Immune Simulation**: C-ImmSim analysis
